JANSSEN-CILAG FARMACEUTICA, LDA secures contract for Ad/4144/2025 Acquisition Of Amivantamab 50 Mg/Ml Sol Inj Fr 7 Ml Iv, For Ulstmad, Epe

Portugal, March 2 -- Portugal based JANSSEN-CILAG FARMACEUTICA, LDA has secured contract from Unidade Local De Saude De Tras-Os-Montes E Alto Douro, E. P. E. for Ad/4144/2025 Acquisition Of Amivantamab 50 Mg/Ml Sol Inj Fr 7 Ml Iv, For Ulstmad, Epe. The value of the contract is worth 7313600 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....